EnglishSparklingWines.com Releases Updated Analysis: Highlights Growing Attention Toward English Sparkling WineDecember 07, 2025 6:57 AM EST | Source: GYTLondon, United Kingdom--(Newsfile Corp. - December 7, 2025) - UK-based e-commerce platform dedicated to Britain's greatest fizz, EnglishSparklingWines.com, has presented an updated analysis on the category's increasing global reputation. The newly released analysis provides insights into the expanding awareness and heightened interest surroun ...

Payre: Solving Late Payments Woes by Making Legal Debt Recovery Platform Accessible to AllDecember 07, 2025 6:57 AM EST | Source: GYTNew York, New York--(Newsfile Corp. - December 7, 2025) - For the first time, creditors can recover debtor arrears through an accountant or lawyer with zero upfront costs -and it's 10x faster.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8530/276800_3344d896544bb81b_001full.jpgPayre (https://www.payre.co), today a ...

Core Points - Rosen Law Firm has announced a class action lawsuit on behalf of investors of Sprouts Farmers Market, Inc. for the period between June 4, 2025, and October 29, 2025, with a deadline for lead plaintiff applications set for January 26, 2026 [2][4] Group 1: Class Action Details - Investors who purchased Sprouts Farmers Market securities or sold put options during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3] - The lawsuit alleges that the defendants provided misleading information regarding Sprouts Farmers Market's growth potential, claiming resilience against macroeconomic pressures while concealing adverse facts that indicated a potential slowdown in sales growth [6] Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their past successes and recognition in the field [5] - Investors are encouraged to join the class action by contacting the firm directly for more information [4][7]

Core Viewpoint - Rosen Law Firm is encouraging investors of Skye Bioscience, Inc. to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to misleading statements made by the company during the class period from November 4, 2024, to October 3, 2025 [2][6]. Group 1: Class Action Details - Investors who purchased Skye securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 16, 2026 [4]. - The lawsuit alleges that Skye's management made materially false and misleading statements regarding the effectiveness and prospects of its product, nimacimab, leading to investor damages when the truth was revealed [6]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [5]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [5]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and success in this area [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [1][2]. Group 1: Class Action Details - Investors who purchased Perrigo securities between February 27, 2023, and November 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 16, 2026 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Perrigo - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment [5]. - It is claimed that Perrigo needed to make substantial capital and operational expenditures beyond its stated cost estimates to address issues in the infant formula business [5]. - The lawsuit also points out significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results, including earnings and cash flow [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of MoonLake Immunotherapeutics who incurred losses exceeding $100,000 to seek legal counsel before the December 15, 2025 deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased MoonLake common stock between March 10, 2024, and September 29, 2025, may be eligible for compensation without any upfront fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the December 15, 2025 deadline to serve as lead plaintiff, which involves directing the litigation on behalf of other class members [3][6]. - The lawsuit claims that during the class period, the defendants made false or misleading statements regarding the efficacy of their product SLK compared to traditional monoclonal antibodies, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4].

Core Viewpoint - Rosen Law Firm is urging investors of Marex Group plc who incurred losses exceeding $100,000 during the specified Class Period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications in a securities class action lawsuit [1][2]. Group 1: Legal Action Details - The class action pertains to securities purchased between May 16, 2024, and August 5, 2025, and investors may be eligible for compensation without upfront costs through a contingency fee arrangement [2][5]. - Investors wishing to participate must file a motion with the Court by December 8, 2025, to serve as lead plaintiff, representing other class members in the litigation [3][6]. Group 2: Allegations Against Marex Group - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements among subsidiaries [5]. - It is claimed that these misrepresentations led to unreliable financial statements and that positive statements about Marex's business were materially misleading [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at that time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions for investors, with over $438 million secured in 2019 alone [4].

Core Points - Rosen Law Firm is encouraging investors of Avantor, Inc. who incurred losses exceeding $100,000 during the class period from March 5, 2024, to October 28, 2025, to secure counsel before the December 29, 2025, lead plaintiff deadline [1] - Investors who purchased Avantor common stock during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - The lawsuit alleges that Avantor's competitive positioning was misrepresented, and the company faced negative impacts from increased competition, leading to materially false and misleading statements about its business and prospects [5] Legal Process - To join the Avantor class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6] - A lead plaintiff must file a motion with the court by December 29, 2025, to represent other class members in the litigation [3] - No class has been certified yet, meaning investors are not represented by counsel unless they retain one [7] Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4] - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]

Core Viewpoint - Rosen Law Firm is encouraging investors of DexCom, Inc. who suffered losses exceeding $100,000 during the specified class period to seek legal counsel before the December 29, 2025 deadline for lead plaintiff applications [1][2]. Group 1: Class Action Details - Investors who purchased DexCom securities between July 26, 2024, and September 17, 2025, may be eligible for compensation without any upfront costs through a contingency fee arrangement [2]. - The lawsuit alleges that DexCom made unauthorized design changes to its G6 and G7 continuous glucose monitoring systems, which compromised their reliability and posed health risks to users [5]. - The defendants are accused of making misleading statements regarding the reliability and functionality of the G6 and G7 devices, which led to increased regulatory scrutiny and potential financial harm to the company [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, having recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - To participate in the class action, investors can visit the provided link or contact the firm directly for more information [3][6].

Core Viewpoint - Rosen Law Firm is encouraging investors of James Hardie Industries plc who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 23, 2025 deadline for lead plaintiff applications [1][3]. Group 1: Class Action Details - Investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025, may be eligible for compensation without any upfront costs through a contingency fee arrangement [2]. - A class action lawsuit has already been filed against James Hardie Industries plc, alleging that the company misled investors regarding the performance of its North America Fiber Cement segment during the class period [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including the largest settlement against a Chinese company and significant recoveries for investors in recent years [4]. Group 3: Case Specifics - The lawsuit claims that James Hardie Industries misrepresented the strength of demand for its products, despite knowledge of distributor destocking, leading to investor damages when the truth was revealed [5].